Homepage | Fintepla HCP Learn about FINTEPLA®, a treatment for seizures associated with Dravet syndrome and LGS, and get full Prescribing Information, including Boxed Warning
FINTEPLA® (fenfluramine) | Official Patient Website FINTEPLA is a prescription medicine used to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older It is not known if FINTEPLA is safe and effective in children less than 2 years of age
Fintepla (fenfluramine): Uses, Side Effects, Dosage Reviews Fintepla (fenfluramine) is an antiepileptic (antiseizure) medication that's used for people ages 2 years and older This medication is only meant for those with seizures caused by Dravet syndrome or Lennox-Gastaut syndrome, not other seizure conditions Fintepla (fenfluramine) comes as an oral solution, so it's a good option for people who can't swallow pills
Fintepla (fenfluramine) - Uses, Side Effects, and More Overview: Fintepla is used to treat certain types of seizures It may work by blocking certain signals that come from nerves and cause seizures Common side effects include weight loss, sleepiness
U. S. FDA Approves FINTEPLA[®] (fenfluramine) Oral Solution . . . FINTEPLA® (fenfluramine) oral solution is a prescription medication approved by the FDA and authorized by the EU Commission, and under regulatory review with the PMDA (Japan), for the treatment of seizures associated with Dravet syndrome in patients two years of age and older 8,12 A Type II Variation Application has also been submitted to the
FINTEPLA® Prescriber Resources | FINTEPLA (fenfluramine) oral . . . Download FINTEPLA® resources for your practice In the randomized, double-blind, placebo-controlled trial of FINTEPLA in LGS, the primary endpoint was the change in frequency of the following seizure types that were confirmed by The Epilepsy Study Consortium to have resulted in a drop, fall, or injury: generalized tonic-clonic (GTC), secondarily GTC, tonic, atonic, and tonic-atonic